Advertisement

Topics

Lupin Q4 Fails To Cheer But Signals Stabilization Of US Generic Market

20:23 EDT 16 May 2019 | SCRIP

Lupin’s management refer to multiple indicators suggesting the US generics segment is stabilizing. But traction for some key launches, delivering...

      

Related Stories

 

Original Article: Lupin Q4 Fails To Cheer But Signals Stabilization Of US Generic Market

NEXT ARTICLE

More From BioPortfolio on "Lupin Q4 Fails To Cheer But Signals Stabilization Of US Generic Market"

Advertisement
Quick Search
Advertisement
Advertisement